Skip to content

Vegetarian Tube Feed Study

Acceptability (Including Gastrointestinal Tolerance, Compliance) of a Vegetarian Paediatric Enteral Tube Feed With Food Derived Ingredients.

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07378111
Acronym
Tube feed
Enrollment
25
Registered
2026-01-30
Start date
2026-03-30
Completion date
2026-12-22
Last updated
2026-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Paediatric

Brief summary

This is a single arm, prospective, single-centre study to evaluate the gastrointestinal tolerance and compliance over a 28-day period using a tube feed with food derived ingredients.

Detailed description

Acceptability (including gastrointestinal tolerance, compliance of a paediatric vegetarian tube feed with food derived ingredients. Gastrointestinal tolerance will data will be collected using a 4point Likert scale, daily record of tube feed volume intake.

Interventions

DIETARY_SUPPLEMENTpaediatric tube feed

500ml tube feed to be provided daily over 28 days.

Sponsors

Société des Produits Nestlé (SPN)
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Years to 15 Years
Healthy volunteers
No

Inclusion criteria

* Patients from 1 -15 years requiring more than 50% of energy from tube feeding or to take alongside home-made blended diet as part of their dietary management for disease related malnutrition. * Patients well-established and stable on current nutritional support regimen. Willingly given, written, informed consent from patient/caregiver

Exclusion criteria

* No established tube feed. * Inability to comply with the study protocol, in the opinion of the investigator. * Under 1 years of age * Patients on parenteral nutrition * Known food allergies, including to any ingredients listed in appendix 1. * Participation in another interventional study within 2 weeks of this study. * Patients with known or suspected ileus or mechanical bowel obstruction

Design outcomes

Primary

MeasureTime frameDescription
Gastrointestinal tolerance and formula intakeFrom enrolment to end of study over 28 daysDaily gastrointestinal tolerance measured using a 4 point Likert scale of none, mild, moderate, severe symptoms over days.
Formula volume intake in mLFrom enrolment to end of study over 28 daysFormula intake measured daily in mLs over 28 days.

Contacts

CONTACTSharan BSc (hons), Nutrition and Dietetics
sharan.saduera@uk.nestle.com+447557170649
PRINCIPAL_INVESTIGATORDr Graeme O'Connor, PHD

Great Ormond Street Hospital Nutrition and Dietetics Department

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 13, 2026